Behcet’s disease presenting as malignant hypertension induced by renovascular hypertension
CEN Case Reports · 2024
DOI: 10.1007/s13730-024-00918-7 ↗Kurz gefasst
Fallbericht in der Zeitschrift CEN Case Reports, 2024. Verfasst von Sho Kinguchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236…. Hauptthemen laut MEDLINE: Behcet Syndrome, Hypertension, Renovascular, Hypertension, Malignant. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hypertension is an uncommon manifestation of Behcet's disease, which is also an uncommon cause of renovascular hypertension. We herein report a case of malignant hypertension associated with unilateral renal artery stenosis due to vascular Behcet's disease. A 19-year-old man, who had no significant medical history, was referred to ophthalmology at our hospital because he was suspected to have uveitis and Vogt-Koyanagi-Harada syndrome. In addition to poor eyesight, he had been aware of a fever, loss of appetite, and weight loss for a month. He was admitted with markedly elevated blood pressure (222/140 mmHg), hypertensive retinopathy, and acute kidney injury, who was diagnosed with malignant hypertension. Laboratory findings showed high plasma renin activity and plasma aldosterone concentration, hypokalemia, and elevated inflammatory response. Computed tomography showed an atrophic right kidney and a compensatorily enlarged left kidney. Renal computed tomography angiography revealed severe and diffuse stenosis of the right renal artery, and stenosis of the ostium of celiac artery. Since he was suspected to have uveitis and his inflammatory responses were elevated on admission, we listed Behcet's disease as a differential diagnosis. Medical interview and examination focusing on Behcet's disease revealed that the patient had recurrent oral aphthous lesions and folliculitis, and a positive pathergy test, which led to the patient being diagnosed with vascular Behcet's disease. After admission, his blood pressure was well controlled with multiple antihypertensive drugs including an angiotensin receptor/neprilysin inhibitor, and his oral aphthous lesions and skin lesion were improved with colchicine. When young men who are at a higher risk for vascular Behcet's disease show renovascular hypertension with an elevated inflammatory reaction, vascular Behcet's disease should be considered as a differential diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
- Department of Nephrology and Hypertension, Yokohama City University Center Hospital, Yokohama, Japan.
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. hiro1234@yokohama-cu.ac.jp.
Zitieren
APA
Kinguchi, S., Tamura, M., Furuta, R., Toyota, K., Ishiga, K., Kanaoka, T., Azushima, K., Wakui, H., Hirawa, N., & Tamura, K. (2024). Behcet’s disease presenting as malignant hypertension induced by renovascular hypertension. CEN Case Reports. https://doi.org/10.1007/s13730-024-00918-7
Vancouver
Kinguchi S, Tamura M, Furuta R, Toyota K, Ishiga K, Kanaoka T, et al. Behcet’s disease presenting as malignant hypertension induced by renovascular hypertension. CEN Case Reports. 2024. doi:10.1007/s13730-024-00918-7
BibTeX
@article{Kinguchi2024,
author = {Kinguchi, Sho and Tamura, Misumi and Furuta, Rika and Toyota, Kazuki and Ishiga, Kohei and Kanaoka, Tomohiko and Azushima, Kengo and Wakui, Hiromichi and Hirawa, Nobuhito and Tamura, Kouichi},
title = {Behcet’s disease presenting as malignant hypertension induced by renovascular hypertension},
journal = {CEN Case Reports},
year = {2024},
doi = {10.1007/s13730-024-00918-7}
}
EUVIMED